Core Viewpoint - The stock of Kefu Medical (301087) has experienced a decline, with a closing price of 40.88 yuan on November 21, 2025, down by 3.36% from the previous day [1] Financial Performance - Kefu Medical reported a total revenue of 2.398 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 6.63% [3] - The net profit attributable to shareholders for the same period was 260 million yuan, up by 3.3% year-on-year [3] - In Q3 2025, the company achieved a single-quarter revenue of 902 million yuan, a significant increase of 30.72% year-on-year [3] - The net profit for Q3 2025 was approximately 92.83 million yuan, reflecting a year-on-year growth of 38.68% [3] - The company’s gross profit margin stands at 53.35%, which is higher than the industry average of 51.22% [3] Market Position - Kefu Medical's total market capitalization is 8.54 billion yuan, which is below the industry average of 10.906 billion yuan, ranking 43 out of 124 in the medical device sector [3] - The company has a price-to-earnings (P/E) ratio of 24.61, significantly lower than the industry average of 54.54, ranking 24 out of 124 [3] - The price-to-book (P/B) ratio is 1.81, compared to the industry average of 3.77, ranking 33 out of 124 [3] Investment Sentiment - Over the past 90 days, 9 institutions have rated Kefu Medical with a buy recommendation, with an average target price of 53.84 yuan [4]
股票行情快报：可孚医疗（301087）11月21日主力资金净卖出231.72万元